These translational observations, in addition to the ability of co-mutation of TP53 with NF1 to result in MPMST development in mouse models, indicate that TP53 inactivation contributes to the progression of neurofibroma and represents a substantial risk of MPNST transformation [40,41]. The gene discussed is NF1; the disease is malignant peripheral nerve sheath tumor.